Clinical trial phase ii. Medical search. Images

Home page Questions and answers Statistics Donations Contact

Anatomy1

Cell Line, Tumor

Organisms1

Diseases51

Neoplasms Lung Neoplasms Disease Progression Neoplasm Metastasis Neoplasm Recurrence, Local Neutropenia Breast Neoplasms Carcinoma, Non-Small-Cell Lung Leukopenia Nausea Recurrence Thrombocytopenia Colorectal Neoplasms Brain Neoplasms Melanoma Vomiting Ovarian Neoplasms Prostatic Neoplasms Drug-Related Side Effects and Adverse Reactions Hematologic Diseases Fatigue Kidney Neoplasms Stroke Peritoneal Neoplasms Stomach Neoplasms Carcinoma, Renal Cell Head and Neck Neoplasms Carcinoma, Squamous Cell Diarrhea Liver Neoplasms HIV Infections Pancreatic Neoplasms Acute Disease Carcinoma, Small Cell Sarcoma Glioblastoma Pain Asthenia Biliary Tract Neoplasms Carcinoma Glioma Lymphoma, Non-Hodgkin Chronic Disease Mesothelioma Anemia Pleural Neoplasms Bone Neoplasms Stomatitis Urologic Neoplasms Rectal Neoplasms Exanthema

Chemicals and Drugs81

Antineoplastic Agents Deoxycytidine Paclitaxel Cisplatin Taxoids Placebos Fluorouracil Antibodies, Monoclonal, Humanized Antineoplastic Agents, Phytogenic Camptothecin Organoplatinum Compounds Carboplatin Antibodies, Monoclonal Antimetabolites, Antineoplastic Vinblastine Quinazolines Dacarbazine Doxorubicin Leucovorin Drugs, Investigational Antineoplastic Agents, Alkylating Benzenesulfonates Phenylurea Compounds Drug Combinations Cyclophosphamide Niacinamide Epothilones Etoposide Angiogenesis Inhibitors Tegafur Protein Kinase Inhibitors Oxonic Acid Pyridines Pyrroles Epirubicin Ifosfamide Thalidomide Vincristine Pyrazines NAD(P)H Dehydrogenase (Quinone)Pyrimidines Cancer Vaccines Recombinant Proteins Tumor Markers, Biological Biological Markers Antibodies, Monoclonal, Murine-Derived Bridged Compounds Prednisone Antibiotics, Antineoplastic Anthracyclines Indoles Boronic Acids Methotrexate Thiophenes Estramustine Piperazines Anticarcinogenic Agents Sulfonamides Guanine Granulocyte Colony-Stimulating Factor Benzamides Interferon-alpha Depsipeptides Immunologic Factors Antineoplastic Agents, Hormonal Prostate-Specific Antigen Quinolines Biomarkers, Pharmacological Sirolimus Mitoxantrone Piperidines Nitrogen Mustard Compounds Triazoles Platinum Compounds Pyrazoles Receptor, Epidermal Growth Factor Immunosuppressive Agents Anti-Bacterial Agents Glutathione Transferase NF-E2-Related Factor 2 Anti-HIV Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment81

Clinical Trials as Topic Clinical Trials, Phase II as Topic Treatment Outcome Clinical Trials, Phase III as Topic Drug Administration Schedule Antineoplastic Combined Chemotherapy Protocols Clinical Trials, Phase I as Topic Research Design Double-Blind Method Controlled Clinical Trials as Topic Infusions, Intravenous Disease-Free Survival Drug Evaluation Randomized Controlled Trials as Topic Survival Analysis Patient Selection Multicenter Studies as Topic Combined Modality Therapy Follow-Up Studies Placebos Administration, Oral Survival Rate Prospective Studies Clinical Protocols Endpoint Determination Maximum Tolerated Dose Clinical Trials, Phase IV as Topic Single-Blind Method Neoplasm Staging Sample Size Drug Therapy, Combination Pilot Projects Early Termination of Clinical Trials Kaplan-Meier Estimate Feasibility Studies Salvage Therapy Prognosis Remission Induction Severity of Illness Index Chemotherapy, Adjuvant Treatment Failure Risk Factors Risk Assessment Reproducibility of Results Neoadjuvant Therapy Questionnaires Data Interpretation, Statistical Drug Approval Area Under Curve Cross-Over Studies Pain Measurement Immunotherapy Random Allocation Injections, Intravenous Phytotherapy Molecular Targeted Therapy Exercise Therapy Meta-Analysis as Topic Injections, Subcutaneous Therapeutic Human Experimentation Retrospective Studies Radiotherapy, Adjuvant Analysis of Variance Predictive Value of Tests Cohort Studies Drug Evaluation, Preclinical Probability Statistics, Nonparametric Proportional Hazards Models Multivariate Analysis Dose Fractionation Control Groups Sensitivity and Specificity Genetic Therapy Models, Statistical Chemoprevention Confidence Intervals Chemoradiotherapy Magnetic Resonance Imaging Therapies, Investigational Administration, Intravenous

Psychiatry and Psychology3

Patient Compliance Pain Cognitive Therapy

Phenomena and Processes10

Metabolic Detoxication, Phase II Time Factors Dose-Response Relationship, Drug Maximum Tolerated Dose Drug Resistance, Neoplasm Area Under Curve Pain Probability Sensitivity and Specificity Pregnancy

Disciplines and Occupations6

Research Design Outcome Assessment (Health Care)Medical Oncology Evidence-Based Medicine Biomedical Research Therapeutic Human Experimentation

Anthropology, Education, Sociology and Social Phenomena7

Quality of Life Informed Consent Drug Approval United States Food and Drug Administration National Cancer Institute (U.S.)Patient Education as Topic National Institutes of Health (U.S.)

Technology, Industry, Agriculture2

Dietary Supplements Drug Industry

Humanities1

Quality of Life

Information Science4

Survival Rate Questionnaires Data Interpretation, Statistical Publishing

Named Groups2

Research Subjects Patient Dropouts

Health Care64

Clinical Trials as Topic Clinical Trials, Phase II as Topic Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase I as Topic Double-Blind Method Controlled Clinical Trials as Topic Disease-Free Survival Randomized Controlled Trials as Topic Survival Analysis Patient Selection Multicenter Studies as Topic Follow-Up Studies Survival Rate Prospective Studies Clinical Protocols Clinical Trials Data Monitoring Committees Clinical Trials, Phase IV as Topic Single-Blind Method Sample Size Pilot Projects Early Termination of Clinical Trials Kaplan-Meier Estimate Feasibility Studies Severity of Illness Index Outcome Assessment (Health Care)Treatment Failure Cost-Benefit Analysis Risk Factors Patient Compliance Risk Assessment Reproducibility of Results Questionnaires Safety Intention to Treat Analysis Data Interpretation, Statistical Informed Consent Area Under Curve Placebo Effect Cross-Over Studies Random Allocation United States Food and Drug Administration Patient Participation Meta-Analysis as Topic Retrospective Studies Analysis of Variance National Cancer Institute (U.S.)Predictive Value of Tests Patient Education as Topic Cohort Studies Bias (Epidemiology)National Institutes of Health (U.S.)Guidelines as Topic Probability Patient Satisfaction Statistics, Nonparametric Proportional Hazards Models Practice Guidelines as Topic Research Support as Topic Multivariate Analysis Age Factors Sensitivity and Specificity Models, Statistical Confidence Intervals

Publication Characteristics1

Clinical Trial, Phase II

Geographicals2

United States Europe

No images available that match "clinical trial phase ii"